A laboratory model to explain the survival advantage observed in patients taking adjuvant tamoxifen therapy

Recent Results Cancer Res. 1993:127:23-33. doi: 10.1007/978-3-642-84745-5_4.

Authors

D M Wolf¹, V C Jordan

Affiliation

¹ Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, Madison 53792.

PMID: 8502820
DOI: 10.1007/978-3-642-84745-5_4

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Breast Neoplasms / drug therapy*
Breast Neoplasms / mortality
Breast Neoplasms / pathology
Chemotherapy, Adjuvant
Female
Humans
Models, Biological
Neoplasm Recurrence, Local
Survival Rate
Tamoxifen / therapeutic use*

Substances

Tamoxifen